9 September 2010

Corac

Company Details

Address:
Brunel Science Park , Kingston Lane , Uxbridge , Middlesex UB8 3PQ
Telephone:
01895 813 463
Fax:
01895 813 505
Website:
www.corac.co.uk

Commentary

Intellectual property and engineering group, specialising in direct drive turbo machinery

Executives

Executive Chairman:
Phil Cartmell (1.9% holding)
Chief Executive:
as above (% holding)
Finance Director:
Mark Crawford (0% holding)
Engineering Director:
Julian Reed (.02% holding)

Main Shareholders

Prudential: 13%

Barclays: 6.7%

Calculus Capital: 5.1%

Fidelity: 4.2%

AXA Framlington: 3.1%

Advisers

Nominated Adviser:
Cenkos Securities
Nominated Broker:
Cenkos Securities
Solicitors:
Charles Russell
Auditors:
Grant Thornton
Registrar:
Capita Registrars

Accounts Information

Entry on AIM:
4/7/2001
Issue Price:
105.0p
Interim Results:
Aug
Final Results:
Apr
Year End:
Dec
Accounts Due:
Jun
Int div payment:
n/a
Fin div payment:
n/a
Int net div per share:
nil
Fin net div per share:
nil

Financial History

  2009 2008
Turnover: £1.33m £0.66m
Pre-tax profit: £ (3.68m) £ (3.47m)
EPS: (3.1) p (3.5) p

Associated Articles

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!

Popular News

Latest News

Futura hails product progress 08/09/2010

Consumer healthcare concern Futura Medical says it expects European approval this year for its CSD500 erection-maintaining condom.

Tags: AIM , Deals & contracts , Fundraisings , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Futura Medical

Dana details bid defence 08/09/2010

Dana Petroleum says its shares are worth between £22.70p and £24.65p to support its opposition to Korea National Oil Corporation's bid at £18.

Tags: Commodities , Full list , Growth Stocks

Sector: Oil & Gas Producers

Companies: Dana Petroleum

Abcam 'cautious' after strong growth 07/09/2010

Online antibody distributor Abcam fears public spending cuts might dampen growth after lifting annual pre-tax profits 58.4 per cent to £25.8 million.

Tags: AIM , Cash , Dividends , Growth Stocks

Sector: Pharmaceuticals & Biotechnology

Companies: Abcam

More News

Sectors

Vitesse Media Events